Literature DB >> 21459656

Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease.

C W Hicks1, M M Pandya, I Itin, H H Fernandez.   

Abstract

Impulse-control disorders (ICDs) are becoming more commonly recognized in the Parkinson disease (PD) population. To date, there are no definitive methods of treating dopamine dysregulation syndromes in PD patients. We sought to uncover an effective treatment option for future study. We report a series of 3 PD patients with ICDs who were effectively treated with valproate. Based on these encouraging preliminary observations, future controlled clinical trials investigating the efficacy of valproate for ICDs in PD are recommended.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459656     DOI: 10.1016/j.parkreldis.2011.03.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

Review 1.  [Repetitive impulse-associated behavioral disorders in Parkinson's disease].

Authors:  R Katzenschlager; K S Goerlich; T van Eimeren
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

2.  Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.

Authors:  Ashok Sriram; Herbert E Ward; Anhar Hassan; Sanjay Iyer; Kelly D Foote; Ramon L Rodriguez; Nikolaus R McFarland; Michael S Okun
Journal:  J Neurol       Date:  2012-09-25       Impact factor: 4.849

Review 3.  Drug-Induced Mitochondrial Toxicity.

Authors:  Iain P Hargreaves; Mesfer Al Shahrani; Luke Wainwright; Simon J R Heales
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

4.  Impulse control disorders in Parkinson's disease: background and update on prevention and management.

Authors:  Robert F Leeman; Benjamin E Billingsley; Marc N Potenza
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 5.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

6.  Treatment of dementia with lewy bodies.

Authors:  Brendon P Boot; Eric M McDade; Scott M McGinnis; Bradley F Boeve
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

7.  Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.

Authors:  Sarah J Moum; Catherine C Price; Natlada Limotai; Genko Oyama; Herbert Ward; Charles Jacobson; Kelly D Foote; Michael S Okun
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

8.  Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Authors:  Tiago A Mestre; Antonio P Strafella; Teri Thomsen; Valerie Voon; Janis Miyasaki
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

Review 9.  The functional anatomy of impulse control disorders.

Authors:  Catharina C Probst; Thilo van Eimeren
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

Review 10.  Dopamine Agonists and Impulse Control Disorders: A Complex Association.

Authors:  Marie Grall-Bronnec; Caroline Victorri-Vigneau; Yann Donnio; Juliette Leboucher; Morgane Rousselet; Elsa Thiabaud; Nicolas Zreika; Pascal Derkinderen; Gaëlle Challet-Bouju
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.